Citius Pharma - Rasio nilai perusahaan marang dodolan CTXR

Simbol resmi perusahaan Citius Pharmaceuticals Inc. (CTXR)

The hiring of managers for the commercial launch of products stimulated growth, and the GURU.Markets service features a linear chart of the company's price-to-sales ratio, where the 1845.29 mark characterizes this parameter. This confirms the strategy to create profitable treatments for oncology and critical care, while the patents for Lymphir provide Citius Pharmaceuticals (CTXR) with robust protection of its market niche against replication.

Citius Pharmaceuticals, Inc. (CTXR): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Citius Pharmaceuticals, Inc. - rincian analitis lan metrik utama (CTXR)

Pambiji fundamental perusahaan:CTXR, Citius Pharma
Produk sing diprodhuksi citiuspharma.com

This indicator compares the total enterprise value of the business with its revenue, excluding the impact of debt load to determine the actual premium paid per unit of income. By analyzing the EV/Sales trend, an investor can assess whether market expectations for Citius Pharmaceuticals (CTXR) are justified against the risks of FDA approval delays and the high capital intensity of oncology programs, where an inflated valuation in the absence of commercial success leads to asset impairment.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales